Clinical Trials · NCT06901245

Tirzepatide in PWS, HO and GNSO

RecruitingPhase 4Tirzepatide (Investigational)
Phase
Phase 4
Recruitment status
Recruiting
Sponsor
Grace Kim
Enrollment
36
Start date
May 2025
Locations
3 sites, United States
Primary endpoint
Change in weight
View Tirzepatide compound reference